Novo Nordisk shares plunge after CagriSema obesity drug trial disappoints
Novo Nordisk on Friday revealed disappointing results in a late-stage trial for its experimental next-generation obesity drug ...
FDA approves Eli Lilly’s obesity medication for obstructive sleep apnea
The FDA has expanded the approval of Eli Lilly’s obesity medication Zepbound to include treating moderate to severe ...
Medical News Today10d
Prescription Weight Loss Medication: Best Options and Alternatives
The obesity rate was 30.5% from 1999 to 2000. From 2017 to 2020, it increased to 41.9%. Prescription weight loss medication has become extremely popular because it is easy to take and effective.
FDA approves anti-obesity drug as first sleep apnea medication
The US FDA approved Eli Lilly's Zepbound as the first ever medication for obstructive sleep apnea for patients who also have ...
New York Daily News on MSN11d
Weight loss drugs credited with decline in U.S. obesity rates
Notable decrease seen in South, which had highest prescription rates for Ozempic, Wegovy and other weight loss meds ...
US obesity rates drop for the first time in a decade likely due to popular weight loss medications
The secret agent in the decrease might be semaglutide, a GLP-1 receptor agonist that fuels popular weight loss drugs like ...